Clinical decision support can reduce the risk of cardiovascular disease | Health

THURSDAY, Feb. 10, 2022 (HealthDay News) — Use of clinical decision support systems (CDSS) is associated with improvements in reversible risk of cardiovascular disease (CVD) in patients with the lowest baseline risk levels. higher, according to a study published online February 4 in Open JAMA Network.

Rachel Gold, Ph.D., of Kaiser Permanente Northwest in Portland, Oregon, and colleagues evaluated the impact of a CDSS targeting CVD risk in 70 community health centers (CHCs; 42 randomly assigned to CDSS) . The target population included patients (aged 40-75) with (1) diabetes or atherosclerotic cardiovascular disease and at least one major uncontrolled risk factor for cardiovascular disease or (2) total risk of reversible cardiovascular disease ≥ 10%.

The researchers found that the CDSS was used in 19.8% of 91,988 eligible encounters in the intervention clinic. No population-level reductions were observed in CVD risk in patients in the control or intervention clinics, but the mean reversible risk improved significantly more in the patients in the control clinics compared to those in the control clinics. intervention clinics. When CDSS was used, there were greater decreases in both risk measures in patients with high baseline risk in intervention clinics compared to control clinics: mean reversible risk of -4.4 vs. 2.7%.

“The use of a CDSS in HCCs has the potential to improve the reversible risk of cardiovascular disease in socioeconomically vulnerable high-risk patients; strategies to increase uptake of CDSS in this setting are needed,” write the authors.

Summary/Full text

Editorial

Comments are closed.